Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
CFO and Chief Business Officer
-
Stock Symbol
-
ATHA on Nasdaq
Andrew Gengos - trading volume in the past year for Athira Pharma, Inc.
Holdings reported by Andrew Gengos for Athira Pharma, Inc.
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
97.5K |
$55.2K |
$0.57 |
Sep 5, 2024 |
Direct |
|
|
| Stock Option (Right to Buy) |
280K |
|
|
Feb 14, 2024 |
Direct |
Common Stock |
|
Transactions reported by Andrew Gengos for Athira Pharma, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.